Literature DB >> 24761385

A concurrent episode of two neoplasms in a toddler-age child.

Muaz A Alrazzak1, Jenny Zablahalabi2, Baraa Alrazzak3, Guillermo De Angulo2.   

Abstract

Childhood neoplasms are relatively rare and represent only about 1- 2% of the total incidence of neoplasms in United States. Concurrent episode of childhood cancer is uncommon and usually related to a cancer genetic syndrome. Li Fraumeni Syndrome refers to an autosomal dominant condition that is manifested by the development of certain cancers in early childhood and an increased lifetime risk for developing multiple primary cancers including sarcoma, breast cancer, leukemia, bone cancer, and others. We report a case of a 21-month-old girl who was found to have orbital embryonal rhabdomyosarcoma and adrenocortical tumor concurrently.

Entities:  

Keywords:  Adrenocortical tumor; Li Fraumeni syndrome; orbital rhabdomyosarcoma

Year:  2014        PMID: 24761385      PMCID: PMC3994710          DOI: 10.4103/2231-0770.130347

Source DB:  PubMed          Journal:  Avicenna J Med        ISSN: 2231-0770


  9 in total

1.  Rhabdomyosarcoma: many similarities, a few philosophical differences.

Authors:  Sarah S Donaldson; James R Anderson
Journal:  J Clin Oncol       Date:  2005-02-22       Impact factor: 44.544

2.  Orbital rhabdomyosarcoma in Li-Fraumeni syndrome.

Authors:  Deborah Y Chong; Hakan Demirci; Shawn M Ronan; Andrew Flint; Victor M Elner
Journal:  Arch Ophthalmol       Date:  2007-04

3.  2009 version of the Chompret criteria for Li Fraumeni syndrome.

Authors:  Julie Tinat; Gaelle Bougeard; Stéphanie Baert-Desurmont; Stéphanie Vasseur; Cosette Martin; Emilie Bouvignies; Olivier Caron; Brigitte Bressac-de Paillerets; Pascaline Berthet; Catherine Dugast; Catherine Bonaïti-Pellié; Dominique Stoppa-Lyonnet; Thierry Frébourg
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

4.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.

Authors:  Anita Villani; Uri Tabori; Joshua Schiffman; Adam Shlien; Joseph Beyene; Harriet Druker; Ana Novokmet; Jonathan Finlay; David Malkin
Journal:  Lancet Oncol       Date:  2011-05-19       Impact factor: 41.316

Review 5.  Inherited cancer syndromes in children and young adults.

Authors:  John A D'Orazio
Journal:  J Pediatr Hematol Oncol       Date:  2010-04       Impact factor: 1.289

Review 6.  [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].

Authors:  T Frebourg; A Abel; C Bonaiti-Pellie; L Brugières; P Berthet; B Bressac-de Paillerets; A Chevrier; A Chompret; O Cohen-Haguenauer; O Delattre; J Feingold; J Feunteun; D Frappaz; J P Fricker; P Gesta; P Jonveaux; C Kalifa; C Lasset; B Leheup; J M Limacher; M Longy; C Nogues; D Oppenheim; D Sommelet; F Soubrier; C Stoll; D Stoppa-Lyonnet; H Tristant
Journal:  Bull Cancer       Date:  2001-06       Impact factor: 1.276

7.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

8.  TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset.

Authors:  Carla Pinto; Isabel Veiga; Manuela Pinheiro; Ana Peixoto; Armando Pinto; José M Lopes; Rui M Reis; Carla Oliveira; Manuela Baptista; Lúcia Roque; Fernando Regateiro; Luís Cirnes; Robert M W Hofstra; Raquel Seruca; Sérgio Castedo; Manuel R Teixeira
Journal:  Fam Cancer       Date:  2009-05-26       Impact factor: 2.375

9.  Gastric cancer in individuals with Li-Fraumeni syndrome.

Authors:  Serena Masciari; Akriti Dewanwala; Elena M Stoffel; Gregory Y Lauwers; Hui Zheng; Maria Isabel Achatz; Douglas Riegert-Johnson; Lenka Foretova; Edaise M Silva; Lisa Digianni; Sigitas J Verselis; Katherine Schneider; Frederick P Li; Joseph Fraumeni; Judy E Garber; Sapna Syngal
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.